Japan, Aug. 26 -- MOMENTA PHARMACEUTICALS INC has got intellectual property rights for 'FCRN ANTIBODY AND METHOD OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-023875
Category (FI): C07K16/28,A61K39/395@D,A61P37/06,A61K39/395@N,A61P7/06,A61P7/00,A61P15/06,A61P31/12,A61P31/16,A61P31/14,A61P31/20,A61P1/04,A61P1/16,A61P3/10,A61P5/14,A61P7/04,A61P9/00,A61P11/00,A61P13/12,A61P17/00,A61P17/06,A61P17/14,A61P19/00,A61P19/02,A61P21/00,A61P25/00,A61P27/02,A61P27/16,A61P29/00,A61P29/00,101,A61P31/18,C07K16/18,C12N15/13,C12N15/63@Z,C12N5/10,C12P21/08,A61P21/04,A61P25/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Feb. 20, 2024
Publication Date: May 1, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
